Method for preparing hybrid allergen composition
Through dry heat sterilization, the treatment of mixtures of various food allergens has been solved, and the problems of microbial reduction and food allergen integrity in the prior art have been achieved, and the efficient killing and allergic reaction effect on mixed allergen products is achieved, providing a Effective prevention and treatment of allergies.
Patent Information
- Application Number
- CN202411164898.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2019-06-24
- Filing Date
- 2020-01-23
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art is difficult to effectively prevent and treat allergies, especially food allergies, and existing methods may affect the integrity of food allergens and the effect of allergic reactions when killing microorganisms.
The mixture containing a variety of food allergens is treated by dry heat sterilization. The mixed allergen materials are processed at a temperature of 65°C to 175°C through a dry heat sterilization system to reduce the number of microorganisms and maintain the integrity of food allergens, forming A mixed allergen product that is essentially free of living and replicating organisms.
It has achieved efficient reduction of microorganisms such as aerobic bacteria and salmonella in mixed allergen products, maintained the protein integrity and allergic reaction ability of food allergens, and provided a safe and effective method to prevent and treat allergies.
Smart Images

Figure CN119015406A_ABST
Abstract
Description
[0001] This application is a divisional application of Chinese patent application 202080017162.X (PCT / US2020 / 014748), whose application date is January 23, 2020 and whose invention name is “Method for preparing a mixed allergen composition”.
[0002] CROSS-REFERENCE TO RELATED APPLICATIONS
[0003] This application claims the benefit of and priority to U.S. Provisional Patent Application No. 62 / 795,877, filed on January 23, 2019, and U.S. Provisional Patent Application No. 62 / 865,473, filed on June 24, 2019, the disclosures of which are incorporated herein by reference for all purposes.
[0004] background
[0005] Allergy is a disorder of the immune system characterized by an allergic reaction to normally harmless environmental substances. Allergies are caused by allergens, which may be present in a wide variety of sources, including, but not limited to, pollen or other plant components, dust, mold or fungi, food, additives, latex, blood transfusions, animal or bird dander, insect venom, radiocontrast media, medications, or chemicals. Common allergic reactions include eczema, hives, hay fever, asthma, and reactions to venom. Mild allergies such as hay fever are very common in the population and can cause symptoms such as allergic conjunctivitis, itching, and runny nose. In some people, severe allergies to environmental allergens, dietary allergens, or medications can lead to life-threatening anaphylactic reactions if not treated.
[0006] Food allergy is an adverse immune response to food allergens, such as food proteins. Common food allergens are found in shellfish, peanuts, tree nuts, fish, milk, eggs, soy, and fresh fruits such as strawberries, mangoes, bananas, and apples. Immunoglobulin E (IgE)-mediated food allergies are classified as type I immediate hypersensitivity reactions. These allergic reactions are acute (from a few seconds to an hour), and the accompanying symptoms may include: angioedema (swelling of the soft tissues of the eyelids, face, lips, tongue, larynx, and trachea); urticaria; itching of the mouth, throat, eyes, and skin; gastrointestinal symptoms, such as nausea, vomiting, diarrhea, stomach cramps, and abdominal pain; discharge or nasal congestion; wheezing; shortness of breath; difficulty swallowing; and anaphylaxis (a severe systemic allergic reaction that can lead to death). It is estimated that 1 in 12 children under the age of 21 will be diagnosed with a food allergy, and that health care costs for food allergic reactions exceed $24 billion annually, much of which is attributed to the approximately 90,000 emergency room visits per year due to food-induced anaphylaxis in the United States alone. Additionally, fatal deaths due to fatal food allergies occur each year.
[0007] Therefore, there is a need in the art for allergen compositions that can prevent and / or treat allergies and methods for preparing allergen compositions for preventing and / or treating allergies.
[0008] Overview
[0009] The present disclosure relates, at least in part, to methods of preparing a mixed allergen product that is substantially free of viable, replicating organisms. For example, in certain embodiments, the method includes: providing a bulk mixed allergen material comprising 2 to 20 individual whole food allergens; sterilizing the bulk mixed allergen material by dry heat sterilization, thereby obtaining the mixed allergen product.
[0010] In certain embodiments, the method further comprises providing 2 to 20 individual whole food allergens, and blending the 2 to 20 individual whole food allergens together to obtain a bulk mixed allergen material.
[0011] In other embodiments, the present disclosure provides a method wherein the 2 to 20 individual whole food allergens are selected from almonds, cashews, cod, eggs, hazelnuts, milk, oats, peanuts, pecans, pistachios, salmon, sesame, shrimp, soy, walnuts and wheat.
[0012] In another embodiment, the present disclosure provides a method wherein the blending further comprises blending the 2 to 20 individual whole food allergens with one or more fillers.
[0013] In certain embodiments of the present disclosure, blending comprises charging 2 to 20 individual whole food allergens into a ribbon blender set at about 10 Hz to about 50 Hz for about 10 minutes to about 50 minutes. In other embodiments, the loose mixed allergen material is discharged into a lined vat after blending.
[0014] In certain embodiments, the methods of the present disclosure further comprise filtering the mixed allergen product. In some embodiments, filtering comprises passing the mixed allergen product through a sieve of #5 mesh (US) to #10 mesh (US) on an oscillator for about 1 minute to about 10 minutes.
[0015] In some embodiments, the methods of the present disclosure further comprise passing the mixed allergen product through a rare earth magnet, a metal detector, and a metal separator.
[0016] In certain embodiments, the methods of the present disclosure provide for the application of dry heat sterilization, wherein the dry heat sterilization is performed at a temperature of about 65°C to about 175°C for about 18 hours to about 72 hours. In some embodiments, the dry heat sterilization comprises using a sterilization system having a heating furnace and a heating chamber, wherein the heating furnace provides about 250,000 BTU to about 750,000 BTU of heat to the heating chamber. In certain embodiments, the loose mixed allergenic raw material is first packaged into a heat-resistant package and then dry heat sterilized. In certain embodiments, a temperature probe is placed with the loose mixed allergenic raw material during the sterilization process to monitor the temperature of the dry heat sterilization.
[0017] In certain embodiments of the present disclosure, the mixed allergen product has at least about a 1 log reduction to at least about a 4 log reduction in aerobic bacterial organism plate counts compared to the corresponding unsterilized loose mixed allergen material. In some embodiments, the mixed allergen product has less than about 10,000 CFU / g of aerobic bacterial organisms. In other embodiments, the mixed allergen product has less than about 10 CFU / g of coliforms, Escherichia coli, Enterobacteriaceae, mold, Staphylococcus aureus, and yeast. In certain embodiments, the mixed allergen product has less than about 10 CFU / g of Salmonella. In certain embodiments, the mixed allergen product has less than about 10 CFU / g of Cronobacter. In other embodiments, each of 25 grams of the mixed allergen product, 25 grams of the mixed allergen product, and 375 grams of the mixed allergen product, the mixed allergen product is negative for Listeria species, Cronobacter species, and Salmonella species in a PCR-based test.
[0018] In some embodiments of the present disclosure, the mixed allergen product has a fat content of about 10% to about 20% by weight.
[0019] In other embodiments, the protein integrity of the mixed allergen product is substantially similar to the protein integrity of the corresponding non-sterilized loose mixed allergen material. In some embodiments, the protein integrity of the mixed allergen product is determined by SDS-PAGE.
[0020] In certain embodiments, the mixed allergen product has a protein content of about 40% to about 50% by weight.
[0021] In certain embodiments, the mixed allergen product has from about 1% to about 10% moisture by weight. In other embodiments, the mixed allergen product has a water activity of from about 0.1 to about 0.6.
[0022] In certain embodiments of the present disclosure, the mixed allergen product comprises less than about 10% by weight of particles having a diameter greater than 500 microns.
[0023] In some embodiments, the mixed allergen product is darker in color than the corresponding non-sterilized loose mixed allergen raw material. In other embodiments, the mixed allergen product has a substantially similar taste profile than the corresponding non-sterilized loose mixed allergen raw material.
[0024] In certain embodiments, the methods described herein comprise one or more further applications of dry heat sterilization.
[0025] In an alternative embodiment, the present disclosure describes a method of preparing a mixed allergen product that is substantially free of viable replicating organisms, comprising: providing 2 to 20 individual whole food allergens; sterilizing the 2 to 20 individual whole food allergens individually by dry heat sterilization, thereby obtaining 2 to 20 sterilized individual whole food allergens; and blending the 2 to 20 sterilized individual whole food allergens together, thereby obtaining the mixed allergen product.
[0026] In another embodiment, the present disclosure describes a method of preparing a mixed allergen product substantially free of viable replicating organisms, wherein the method further comprises admixing the mixed allergen product with one or more than one probiotic selected from the group consisting of Lactobacillus rhamnosus, Anaerostipes caccae, and Bifidobactierium longum.
[0027] In yet another embodiment, the mixed allergen product is further blended with one or more than one prebiotic, for example, wherein the prebiotic is fructo-oligosaccharide.
[0028] Also disclosed is a mixed allergen product substantially free of viable replicating organisms prepared by any of the methods disclosed herein.
[0029] BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1Macroscopic images of non-sterilized loose mixed allergen material samples and loose mixed allergen material samples heated in a laboratory oven at 95°C, 105°C, 110°C or 120°C for 5 minutes.
[0031] Figure 2A Schematic diagram showing the placement of trays and sample boxes containing heat-resistant bags of loose mixed allergenic raw materials in a dry heat sterilization chamber for validation test 1. B3 of trays 3, 4, and 12 has a compartment probe placed inside the box for temperature monitoring. B4 of trays 7 and 8 has a compartment probe placed outside the box, and B4 of tray 11 has a compartment probe placed inside the box. Figure 2B Schematic diagram showing sample boxes of trays and heat-resistant bags containing loose mixed allergenic raw materials placed in a dry heat sterilization chamber for validation test 2. B3 of trays 5 and 14 has a compartment probe placed inside the box for temperature monitoring. B4 of trays 4 and 8 has a compartment probe placed inside the box, and B4 of trays 6 and 9 has a compartment probe placed outside the box. The shaded boxes represent empty boxes without heat-resistant bags containing loose mixed allergenic raw materials. The asterisk ("*") represents a box with two heat-resistant bags containing loose mixed allergenic raw materials. "P" represents a box with a MadgeTech probe.
[0032] Figure 3A is a line graph showing the temperature profile of the dry heat sterilization chamber during validation test 1. Figure 3B Figure 2 is a line graph showing the temperature profile of the dry heat sterilization chamber during Validation Test 2. Each line represents the temperature reading of a single compartment probe or MadgeTech probe.
[0033] Detailed Description
[0034] The present application discloses a method for preparing a mixed allergen product that is substantially free of viable and replicative organisms.
[0035] The term "viable and replicable organism" refers to an organism that is able to reproduce, regenerate, proliferate and / or produce colony forming units (CFU) on a plate culture medium.
[0036] The term "sterilization" refers to a process that can substantially reduce the number of organisms that can survive and replicate.
[0037] As used in this application, "an isolated whole food allergen" refers to a food substance that contains all possible antigenic components of the food substance (e.g., allergenic proteins). An isolated whole food allergen may include, but is not limited to, unprocessed or processed food substances, concentrated food substances, and isolated food substances.
[0038] As used in this application, an "allergenic protein" is an antigenic component of a food allergen that is directly or indirectly responsible for causing an allergic response in an organism. Allergenic proteins can include, but are not limited to, nut proteins, such as hazelnut protein (e.g., Cora 1, Cora 2, Cora 6, Cora 8, Cora 9, Cora 10, Cora 11, Cora 12, Cora 13 and Cora 14), cashew protein (e.g., Ana o 1, Ana o2 and Ana o 3), pistachio protein (e.g., Pis v 1, Pis v 2, Pis v 3, Pis v 4 and Pis v 5), walnut protein (e.g., Jug r 1, Jug r 2, Jug r 3, Jug r 4, Jug r5, Jug r 6, Jug r 7 and Jug r 8, Jug n1, Jug n 2 and Jug n 4), pecan protein (e.g., Car i1, Car i2 and Car i 4), almond protein (e.g., Pru du 3, Pru du 4, Pru du 5), and Arah 17), and Brazil nut proteins (e.g., Ber e 1 and Ber e 2).Allergenic proteins can also include, but are not limited to, animal proteins, such as egg proteins (e.g., Gal d 1, Gal d 2, Gal d 3, Gal d 4, Gal d 5, Gal d 6, Gal d 7, Gal d 8, Gal d 9, Gal d 10), milk proteins (e.g., Bos d 2, Bos d 3, Bos d 4, Bos d 5, Bos d, 6, Bos d 7, Bos d 8, Bos d 9, Bos d 10, Bos d 11, and Bos d 12), salmon proteins (e.g., Onc k 5, Sal s 1, Sal s 2, and Sal s 3), cod proteins (e.g., pGad c 1, Gad m 1, Gad m 2, and Gad m 3), shrimp proteins (e.g., Crab protein, 1, Cra c 2, Cra c 4, Cra c 5, Cra c 6, Cra c 8, Lit v 1, Lit v 2, Lig v3, Lit v 4, Met e 1, Pan b 1, Pen a 1, Pen i1, Pen m 1, Pen m 2, Pen m 3, Pen m 4 and Penm 6) and crab proteins (e.g., Cha f 1, Por p 1, Scy p 2, Scy p 4 and Scy p 8).Allergenic proteins can also include, but are not limited to, non-nut plant proteins, such as wheat protein (e.g., Tri a 12, Tri a 14, Tri a 15, Tri a 17, Tri a 18, Tri a 19, Tri a 20, Tri a 21, Tri a 25, Tri a 26, Tri a 27, Tri a 28, Tri a 29, Tri a 30, Tri a 31, Tri a 32, Tri a 33, Tri a 34, Tri a 35, Tri a 36, Tri a 37, Tri a 39, Tri a 40, Tri a 41, Tri a 42, Tri a 43, Tri a 44, and Tri a 45), soy protein (e.g., Gly m 1, Gly m 1.0101, Gly m 2, Gly m 3, Gly m 4, Gly m 5, Gly m 6, Gly m 7, d 10, Act d 11, Act d 12, and Act d 13), carrot protein (e.g., Dau c 1, Dau c 4, and Dau c 5), celery protein (e.g., Api q 1, Api q 2, Api q 3, Api q 4, Api q 5, Api q 6, and Api q 7), 5 and Api q 6), drupe proteins (e.g., Pru ar 1, Pru ar3, Pru av 1, Pru av 2, Pru av 3, Pru av 4, Pru p 1, Pru p 2, Pru p 3, Pru p4, Pru p 7 and Pru d 3) and oat proteins.
[0039] Disclosed herein, for example, is a method for preparing a mixed allergen product that is substantially free of viable and replicative organisms, comprising: providing a loose mixed allergen raw material comprising 2 to 20 individual whole food allergens; and sterilizing the loose mixed allergen raw material by dry heat sterilization, thereby obtaining the mixed allergen product.
[0040] In certain embodiments, the loose mixed allergen material comprises 2 to 20 individual whole food allergens, for example, 4 to 20, 6 to 20, 8 to 20, 10 to 20, 12 to 20, 14 to 20, 16 to 20, 18 to 20, 2 to 18, 4 to 18, 6 to 18, 8 to 18, 10 to 18, 12 to 18, 14 to 18, 16 to 18, 2 to 16, 4 to 16, 6 to 16, 8 to 16, 10 to 16, 12 to 16, or 14 to 16 individual whole food allergens. For example, the loose mixed allergen material may comprise 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 individual whole food allergens. In a specific embodiment, the loose mixed allergen material comprises 15 or 16 individual whole food allergens.
[0041] For example, in certain embodiments, the single whole food allergen is selected from nuts, seeds, legumes, eggs, dairy, fish, and crustaceans. In specific embodiments, the single whole food allergen is selected from almonds, cashews, hazelnuts, peanuts, pecans, pistachios, walnuts, sesame, soy, eggs, milk, oats, wheat, cod, salmon, and shrimp. In certain embodiments, the single whole food allergen is almonds, cashews, hazelnuts, peanuts, pecans, pistachios, walnuts, sesame, soy, eggs, milk, oats, wheat, cod, salmon, and shrimp. It is contemplated that the single whole food allergen may be provided as a meal, food meal, powder, and / or protein concentrate.
[0042] In certain embodiments, the method further comprises providing 2 to 20 individual whole food allergens and blending the 2 to 20 individual whole food allergens together to provide a loose mixed allergen material. It should be understood that two or more individual whole food allergens may be provided in combination prior to blending. For example, 2 to 20, 4 to 20, 6 to 20, 8 to 20, 10 to 20, 12 to 20, 14 to 20, 16 to 20, 18 to 20, 2 to 18, 4 to 18, 6 to 18, 8 to 18, 10 to 18, 12 to 18, 14 to 18, 16 to 18, 2 to 16, 4 to 16, 6 to 16, 8 to 16, 10 to 16, 12 to 16, or 14 to 16 individual whole food allergens may be provided in combination prior to blending. In another example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 individual whole food allergens may be provided in combination prior to admixture.
[0043] It will be appreciated that blending may include one or more than one blending step to obtain a bulked mixed allergen material. For example, the individual whole food allergens may be blended in 1 to 19, 1 to 17, 1 to 15, 1 to 13, 1 to 11, 1 to 9, 1 to 7, 1 to 5, or 1 to 3 blending steps. In a particular embodiment, blending includes mixing the individual whole food allergens in a single blending step.
[0044] As contemplated in the present disclosure, the loose mixed allergenic raw material is sterilized by dry heat sterilization. It is understood that the sterilization may further include one or more additional applications of dry heat sterilization to inactivate heat resistant spores.
[0045] In certain embodiments, dry heat may be applied to a processing chamber of a sterilization system in which the loose mixed allergenic material is contained or conveyed, wherein the processing chamber may be heated to a temperature of about 65° C. to about 175° C. For example, in certain embodiments, the processing chamber may be heated to a temperature of about 65° C. to about 80° C., about 65° C. to about 120° C., about 100° C. to about 150° C., or about 125° C. to about 175° C. In specific embodiments, the processing chamber may be heated to a temperature of about 65° C., about 66° C., about 67° C., about 68° C., about 69° C., about 70° C., about 71° C., about 72° C., about 73° C., about 74° C., about 75° C., about 85° C., about 95° C., about 105° C., about 115° C., about 125° C., about 135° C., about 145° C., about 155° C., about 165° C., or about 175° C. In other embodiments, dry heat may be applied to the loose mixed allergenic material for about 3 minutes to about 72 hours. In certain embodiments, for example, dry heat can be applied for about 3 minutes to about 72 hours, about 30 minutes to about 72 hours, about 12 hours to about 72 hours, about 18 hours to about 72 hours, about 24 hours to about 72 hours, about 30 hours to about 72 hours, about 36 hours to about 72 hours, about 42 hours to about 72 hours, about 48 hours to about 72 hours, about 54 hours to about 72 hours, about 60 hours to about 72 hours, or about 66 hours to about 72 hours. For example, in specific examples, dry heat can be applied to the loose mixed allergy material for about 30 minutes, about 45 minutes, about 60 minutes, about 75 minutes, about 90 minutes, about 105 minutes, about 120 minutes, about 12 hours, about 18 hours, about 24 hours, about 30 hours, about 36 hours, about 42 hours, about 48 hours, about 54 hours, about 60 hours, about 66 hours, or about 72 hours.
[0046] In certain embodiments, for example, dry heat can be provided to the processing chamber of the sterilization system by a plurality of natural gas burners that provide about 250,000 BTUs to about 750,000 BTU of heat to the processing chamber. For example, about 250,000 BTU, about 300,000 BTU, about 350,000 BTU, about 400,000 BTU, about 450,000 BTU, about 500,000 BTU, about 550,000 BTU, about 600,000 BTU, about 650,000 BTU, about 700,000 BTU, or about 750,000 BTU of heat can be provided to the processing chamber.
[0047] In another embodiment, dry heat sterilization may be applied to loose mixed allergenic material packaged in heat resistant packaging. As used in this application, "heat resistant" should be understood to mean that application of heat to the packaging material at the same temperature and duration as simultaneously applied to the loose mixed allergenic material packaged therein does not result in changes to the packaging material that affect its integrity and functionality as a barrier to chemical or microbiological contamination. In addition, "heat resistant" should be understood to mean that application of heat to the packaging material at the same temperature and duration as simultaneously applied to the loose mixed allergenic material packaged therein does not alter the packaging to result in chemicals in the packaging being added to the loose mixed allergenic material packaged therein. For example, the heat resistant packaging may include, but is not limited to, bulk bags, pouches, or stick packaging. In another example, the heat resistant packaging may be placed in a box and / or on a tray or rack within a heating chamber for dry heat sterilization.
[0048] As contemplated in the methods of the present disclosure, blending can include loading 2 to 20 individual material food allergens (e.g., 4-20, 6-20, 8-20, 10-20, 12-20, 14-20, 16-20, 18-20, 2-18, 4-18, 6-18, 8-18, 10-18, 12-18, 14-18, 16-18, 2-16, 4-16, 6-16, 8-16, 10-16, 12-16, or 14-16 individual whole food allergens) into a mechanical agitator or mixer. For example, the mechanical agitator or mixer can be selected from, but not limited to: a ribbon blender; a paddle masher; a plow mixer; a fluidizing agitator; an intensive mixer; a vacuum mixer; a conical mixer; a rotary batch mixer; and a twin-shaft mixer. In one specific embodiment, the individual whole food allergens are loaded into a ribbon blender. Without wishing to be bound by theory, it is believed that blending by loading the individual whole food allergens into a mechanical agitator or mixer reduces grittiness, reduces the number of large particles, and increases homogeneity.
[0049] It will be appreciated that each individual whole food allergen may be loaded into the mechanical stirrer or mixer in varying amounts, such as, but not limited to: about 5 kg to about 100 kg; about 10 kg to about 90 kg; about 15 kg to about 80 kg; about 20 kg to about 70 kg; about 25 kg to about 60 kg; and about 30 kg to about 50 kg. It will be further appreciated that the mechanical stirrer or mixer may hold varying combined total amounts of whole food allergens. In certain embodiments, for example, the mechanical stirrer or mixer may hold a combined total amount of whole food allergens of about 100 kg to about 2200 kg or about 500 kg to about 2000 kg. For example, in some embodiments, the mechanical agitator or mixer can hold about 500 kg, about 600 kg, about 700 kg, about 800 kg, about 900 kg, about 1000 kg, about 1100 kg, about 1200 kg, about 1500 kg, about 1600 kg, about 1700 kg, about 1800 kg, about 1900 kg, or about 2000 kg of a combined total amount of whole food allergens.
[0050] It will also be appreciated that the settings of the mechanical agitator or mixer can be adjusted to achieve optimal blending and / or mixing of the individual whole food allergens. For example, the mechanical agitator can be set at about 10 Hz to about 50 Hz (e.g., about 15 Hz to about 45 Hz, about 20 Hz to about 40 Hz, or about 25 Hz to about 35 Hz). The mechanical agitator can also be set to run for different lengths of time. For example, the mechanical agitator can blend the individual food allergens for about 5 minutes to about 30 minutes, about 7.5 minutes to about 25 minutes, or about 10 minutes to about 20 minutes. In a specific embodiment, the mechanical agitator or mixer is a 1000 kg capacity ribbon blender and blends the individual whole food allergens at 30 Hz for 15 minutes.
[0051] In certain embodiments, the method of the present disclosure further comprises blending 2 to 20 separate whole food allergens with one or more than one filler. The filler contemplated may include any filler described in the present application. In certain embodiments, the filler comprises a sugar, for example, sucrose, maltodextrin, trehalose, trehalose dihydrate, isomalt, mannitol, lactose, glucose, fructose, raffinose, or any combination thereof. In certain embodiments, the filler comprises maltodextrin or sucrose, or a combination thereof.
[0052] In certain embodiments, the loose mixed allergenic material may be discharged from a mechanical blender or mixer into a lined vat and then loaded for sterilization. In other embodiments, the loose mixed allergenic material discharged into the lined vat may be packaged into bags or bags.
[0053] Also contemplated are methods of preparing a mixed allergen product, further comprising filtering the mixed allergen product to remove agglomerated particles. For example, the mixed allergen product may be passed through a sieve ranging from #5 mesh (US) to #10 mesh (US) on an oscillator for about 1 minute to about 10 minutes. For example, the sieve may be a #5 mesh (US) sieve, a #6 mesh (US) sieve, a #7 mesh (US) sieve, a #8 mesh (US) sieve, a #9 mesh (US) sieve, or a #10 mesh (US) sieve. In a specific embodiment, the mixed allergen product is filtered through a sieve ranging from #5 mesh (US) to #10 mesh (US) on an oscillator for about 3 minutes.
[0054] In certain embodiments, the method of preparing a mixed allergen product may further include magnetically screening the mixed allergen product to remove metal particles. For example, magnetic screening may include passing the mixed allergen product through a rare earth magnet, a metal detector, and / or a metal separator. In another example, the metal detector may detect stainless steel particles having a size of at least about 2 mm to about 2.5 mm, iron-containing particles having a size of at least about 1.5 mm to about 2 mm, and nonferrous metal particles having a sensitivity of about 1.5 to 2 parts per million.
[0055] In other embodiments, the method of making a mixed allergen product can be a continuous process wherein the total time to complete the process is about 3 minutes to about 72 hours, about 30 minutes to about 72 hours, about 12 hours to about 72 hours, about 18 hours to about 72 hours, about 24 hours to about 72 hours, about 30 hours to about 72 hours, about 36 hours to about 72 hours, about 42 hours to about 72 hours, about 48 hours to about 72 hours, about 54 hours to about 72 hours, about 60 hours to about 72 hours, or about 66 hours to about 72 hours. For example, in specific instances, the total time to complete the process is about 30 minutes, about 45 minutes, about 60 minutes, about 75 minutes, about 90 minutes, about 105 minutes, about 120 minutes, about 12 hours, about 18 hours, about 24 hours, about 30 hours, about 36 hours, about 42 hours, about 48 hours, about 54 hours, about 60 hours, about 66 hours, or about 72 hours.
[0056] In the method of the present disclosure, a bulk mixed allergen raw material is sterilized by dry heat sterilization to produce a mixed allergen product that is substantially free of viable and replicative organisms.
[0057] In certain embodiments, the mixed allergen products of the present disclosure are substantially free of viable, replicating bacteria, yeasts, and / or molds. In some embodiments, the mixed allergen products may have: at least about 1 log reduction to at least about 9 log reduction in aerobic biological plate counts; at least about 1 log reduction to about 4 log reduction; at least about 1 log reduction to about 5 log reduction; at least about 1 log reduction to about 6 log reduction; at least about 1 log reduction to about 7 log reduction; at least about 1 log reduction to about 8 log reduction or at least about 3 log reduction to about 9 log reduction, compared to a corresponding loose mixed allergen material that has not been sterilized. For example, the mixed allergen product may have at least about 1 log reduction, at least about 2 log reduction, at least about 3 log reduction, at least about 4 log reduction, at least about 5 log reduction, at least about 6 log reduction, at least about 7 log reduction, at least about 8 log reduction, or at least about 9 log reduction in aerobic biological plate counts compared to a corresponding loose mixed allergen material that has not been sterilized. In another example, the mixed allergen product has less than about 100,000 CFU / g, 10,000 CFU / g, less than about 1,000 CFU / g, less than about 100 CFU / g, or less than about 10 CFU / g of aerobic organisms. In another example, the mixed allergen product has less than about 100 CFU / g, less than about 10 CFU / g, or less than about 1 CFU / g of coliforms. In yet another example, the mixed allergen product may have less than about 10 CFU / g of pathogenic microbial strains. For example, the mixed allergen product has less than about 100 CFU / g, less than about 10 CFU / g, or less than about 1 CFU / g of Escherichia coli. In another example, the mixed allergen product has less than about 100 CFU / g, less than about 10 CFU / g, or less than about 1 CFU / g of Enterobacteriaceae. In another example, the mixed allergen product has less than about 100 CFU / g or less than about 10 CFU / g of Salmonella. In another example, the mixed allergen product has less than about 100 CFU / g or less than about 10 CFU / g of Cronobacter. In yet another example, the mixed allergen product is negative for Listeria species or Cronobacter species per 25 grams of the mixed allergen product sample as determined by a PCR-based detection method. In another example, the mixed allergen product has less than about 100 CFU / g, less than about 10 CFU / g, or less than about 1 CFU / g of mold. In yet another example, the mixed allergen product is negative for Salmonella species per 375 grams of the mixed allergen product sample as determined by a PCR-based detection method.In another example, the mixed allergen product has less than about 100 CFU / g, less than about 10 CFU / g, or less than about 1 CFU / g of Staphylococcus aureus. In another example, the mixed allergen product has less than about 100 CFU / g, less than about 10 CFU / g, or less than about 1 CFU / g of yeast.
[0058] In certain embodiments, the mixed allergen products of the present disclosure have a fat content of at least about 5% by weight. For example, the mixed allergen product may have a fat content of about 10% to about 20% by weight. In some embodiments, for example, the mixed allergen product may have a fat content of about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19%, or about 20% by weight.
[0059] It is contemplated that applying dry heat sterilization to the loose mixed allergen material does not substantially alter the protein integrity. For example, in certain embodiments, the sterilized mixed allergen product has the same protein integrity as the corresponding non-sterilized loose mixed allergen material. In another example, the protein integrity is determined by SDS-PAGE, wherein the mixed allergen product has substantially similar protein bands, protein band distributions, and protein band intensities as the non-sterilized loose mixed allergen material.
[0060] It is further contemplated that the application of dry heat sterilization to the bulk mixed allergen material does not substantially affect the ability of the bulk mixed allergen material to elicit an allergenic effect when consumed by an individual. As used herein, "allergenic effect" is understood to mean an immune response to one or more than one antigenic component, characterized by, but not limited to, immune cell activation, cytokine production, and IgE production. In certain embodiments, the mixed allergen product, when consumed by an individual, has an allergenic effect substantially similar to that of the corresponding bulk mixed allergen material without sterilization, consuming a substantially similar amount of protein. In certain embodiments, the allergenic effect is determined by the production of IgE or cytokines, or by measuring the immune cell activation response produced by an individual in response to consumption of the bulk mixed allergen material or mixed allergen product. In other embodiments, the allergenic effect is determined by an in vitro immune response, e.g., measuring the production of IgE or cytokines, or measuring the activation of immune cell cultures after treatment with the bulk mixed allergen material or mixed allergen product.
[0061] In certain embodiments, the mixed allergen products of the present disclosure have a protein content of about 40% to about 50% by weight. For example, the mixed allergen product may have a protein content of about 40%, about 41%, about 42%, about 43%, about 44%, about 45%, about 46%, about 47%, about 48%, about 49%, or about 50% by weight.
[0062] In certain embodiments, the mixed allergen products of the present disclosure have about 1% to about 10% moisture by weight. For example, the mixed allergen products may have about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10% moisture by weight.
[0063] In certain embodiments, the mixed allergen product of the present disclosure has a water activity of about 0.1 to about 0.6. "Water activity" should be understood as the ratio of the vapor pressure of the mixed allergen product to the vapor pressure of distilled water under the same conditions. It will be understood that water activity is a measure of water that is not bound to the molecules of the mixed allergen product and is therefore capable of supporting the growth of bacteria, yeasts and molds. In addition, it will be understood that water activity can be measured using suitable electronic instruments such as hygrometers, moisture-hygrometers, hygrometers and relative humidity systems.
[0064] In certain embodiments, the mixed allergen products of the present disclosure have less than about 10% by weight of particles having a diameter greater than 500 microns.
[0065] In yet another embodiment, the mixed allergen product of the present disclosure has substantially similar taste characteristics compared to the corresponding loose mixed allergen material without sterilization. For example, the mixed allergen product may have one or more than one flavor selected from, but not limited to, salty, nutty, seafood, barbecue and brown seasoning. In another example, the mixed allergen product is free of any off-flavors resulting from processing.
[0066] In another embodiment, a method of preparing a mixed allergen product substantially free of viable replicating organisms is contemplated, wherein the 2 to 20 individual food allergens are sterilized by dry heat sterilization prior to blending to obtain the mixed allergen product.
[0067] In certain embodiments, the method of preparing a mixed allergen product further comprises admixing the mixed allergen product with one or more than one probiotic selected from the group including, but not limited to, Lactobacillus species, Bifidobacterium species, Anacaerostipes species, and Bacillus species. For example, the one or more probiotics can be selected from the group including, but not limited to, Lactobacillus rhamnosis, Corynebacterium faecalis, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus brevis, Lactobacillus salivarius, Lactococcus lactis, Bacillus coagulans, Lactobacillus bulgaricus, Lactobacillus gasseri, Lactobacillus paracasei, Bacillus coagulans, and Bifidobacterium bifidum. In a specific embodiment, the method of preparing a mixed allergen product further comprises admixing the mixed allergen product with Lactobacillus rhamnosus and / or Bifidobacterium longum.As used in this application, "probiotics" refers to a culture (pure or mixed) containing microorganisms that, when ingested, produce a beneficial effect on the host.
[0068] In other embodiments, the method of preparing a mixed allergen product further comprises blending the mixed allergen product with one or more prebiotics selected from the group including, but not limited to, fructooligosaccharides, inulin, isomaltooligosaccharides, lactitol, lactosucrose, lactulose, pyrodextrin, soy oligosaccharides, xylooligosaccharides, transgalacto-oligosaccharides, oligosaccharides, soluble corn fiber, β-glucan, oligofructose and dimers. In a specific embodiment, the method of preparing a mixed allergen product further comprises blending the mixed allergen product with fructooligosaccharides. As used in this application, the term "prebiotic" refers to a specific dietary food or nutrient that promotes the growth, proliferation and / or activity of a specific, desired bacterial strain.
[0069] The disclosed mixed allergen products may also contain one or more vitamins as desired. The vitamins that may be present include, for example, vitamin A (e.g., in an amount of about 1 to about 35,000 international units), vitamin C (e.g., in an amount of about 1 to about 1,000 milligrams), vitamin D (e.g., in an amount of about 1 to about 4,000 international units, i.e., in an amount of about 0.025 to about 100 micrograms), vitamin E (e.g., in an amount of about 1 to about 450 international units), vitamin K (e.g., in an amount of about 1 to about 250 micrograms), vitamin B-1 (thiamine; e.g., in an amount of about 1 to about 15 milligrams), vitamin B-2 (riboflavin; e.g., in an amount of about 1 to about 17 mg), vitamin B-3 (niacin; e.g., in an amount of about 1 to about 200 mg), vitamin B-5 (pantothenic acid; e.g., in an amount of about 1 to about 100 mg), vitamin B-6 (pyridoxine; e.g., in an amount of about 1 to about 30 mg), vitamin B-9 (folic acid; e.g., in an amount of about 1 to about 4,000 μg), vitamin B-12 (cobalamin; e.g., in an amount of about 1 to about 250 μg), vitamin H (biotin; e.g., in an amount of about 1 to about 1,000 μg), and combinations thereof. In certain embodiments, the mixed allergen product comprises vitamin D. In certain embodiments, the mixed allergen product comprises 400 international units, i.e., about 10 μg, of vitamin D.
[0070] Also contemplated are methods of preparing mixed allergen products, wherein the mixed allergen product is further mixed with a physiologically acceptable delivery medium to produce a physiologically acceptable composition. The mixed allergen product may be further incorporated into a variety of formulations for administration to a subject. More specifically, the mixed allergen product may be formulated into a physiologically acceptable composition by combining with an appropriate, physiologically acceptable carrier or diluent (e.g., vegetable oil).
[0071] In certain embodiments, the disclosed mixed allergen products are designed for oral immunotherapy of food allergies in children or adults, for example, as dispersible powders or granules, foods, tablets, lozenges, pastilles, gummies, emulsions, etc. Compositions intended for oral use may be prepared according to any convenient protocol for making oral compositions, and such compositions may contain one or more substances selected from sweeteners (e.g., glycerol, propylene glycol, sorbitol or sucrose), flavoring agents, coloring agents and preservatives, in order to provide a suitable formulation.
[0072] Also contemplated are methods of preparing mixed allergen products, wherein the mixed allergen product is mixed or blended with a food to which a child or adult is not allergic. For example, the food may include, but is not limited to: infant or toddler formula, baby food (e.g., pureed food suitable for infants or toddlers), potato chips, biscuits, bread, spreads, cream, yogurt, liquid beverages, chocolate-containing products, candy, ice cream, cereals, coffee, pureed food, etc.
[0073] Throughout the specification, when devices, apparatuses, and systems are described as having, including, or comprising specific components, or when processes and methods are described as having, including, or comprising specific steps, it is contemplated that there are additional devices, apparatuses, and systems consisting essentially of or consisting of the enumerated components, and that there are processes and methods consisting essentially of or consisting of the enumerated process steps.
[0074] All examples provided in this application are for illustrative purposes only and should not be construed as limiting in any way. Example
[0075] Example 1
[0076] This example describes the selection of allergenic food ingredients for inclusion in an exemplary dry powdered mixed allergen product containing 16 individual whole food allergens (almonds, cashews, hazelnuts, peanuts, pecans, pistachios, walnuts, sesame, soy, egg, milk, oats, wheat, cod, salmon, and shrimp).
[0077] Sources of ingredients were focused primarily on domestic commercial availability, with the exception of individual whole food allergens that were only available internationally. Successful commercial procurement of multiple options for each of the individual whole food allergens led to the development of selection criteria to select the best commercial food allergens to be tested. Attributes screened included: protein content; bulking material content; organoleptic properties such as taste, presence of off-flavors, and grittiness; and solubility. Ingredients with relatively low protein content or with a large proportion of bulking material were eliminated from competition. The individual whole food allergens were dry tasted to determine the presence of off-flavors and to assess grittiness.
[0078] Table 1 shows a sample formulation for a mixed allergen product and representative pre-weighed batch sizes of individual whole food allergens provided for blending and sterilization.
[0079] Table 1
[0080]
[0081]
[0082] Example 2
[0083] This example describes an exemplary blending process for preparing a mixed allergen product containing 16 individual whole food allergens (almonds, cashews, hazelnuts, peanuts, pecans, pistachios, walnuts, sesame, soy, egg, milk, oats, wheat, cod, salmon, and shrimp).
[0084] A 1,000 kg ribbon blender (Prince Industries, India) was cleaned, sanitized and tested for adenosine triphosphate (ATP) and allergens. Actual batches (in kg) of 16 individual whole food allergens shown in Table 1 were charged into the ribbon blender and blended at 30 Hz for 15 minutes.
[0085] The loose mixed allergenic raw materials are discharged from the ribbon blender into lined drums (40 to 50 kg per drum).
[0086] Example 3
[0087] This example describes an alternative blending and milling process for preparing a mixed allergen product containing 16 individual whole food allergens (almonds, cashews, hazelnuts, peanuts, pecans, pistachios, walnuts, sesame, soy, egg, milk, oats, wheat, cod, salmon, and shrimp).
[0088] All individual whole food allergens were weighed to make 8 kg batches. The individual whole food allergens were transferred to a D500 Hobart mixer equipped with a D-30 bowl and a safety cage. The individual whole food allergens were mixed with a paddle attachment "B" plate-shaped mixer on setting 1 for 2 minutes. The blended whole food allergens were transferred to large food grade plastic bags, sealed and stored at room temperature until ground. The blended whole food allergens were slowly fed into a Quadro SLS-L1A FitzMill equipped with a #20 mesh screen and set at 9,000 rpm to achieve a target particle size of <500 microns in diameter. The ground whole food allergens were passed through a metal detector and a #35 mesh screen before packaging.
[0089] Example 4
[0090] Preliminary heat sensitivity testing was performed to determine the suitability of bulk mixed allergenic raw materials for sterilization processing.
[0091] The loose mixed allergenic raw material was placed in a pan and subjected to different temperatures in a laboratory oven for 5 minutes.
[0092] like Figure 1 As shown in , apart from a slight darkening of the color with increasing temperature, the loose mixed allergenic material did not exhibit any other physical changes that would make the material unsuitable for sterilization when heat treated at 95°C, 105°C, 110°C or 120°C for 5 minutes.
[0093] Example 5
[0094] This example describes an exemplary dry heat sterilization process that can be used to prepare a mixed allergen product containing 16 individual food allergens (almonds, cashews, hazelnuts, peanuts, pecans, pistachios, walnuts, sesame, soy, eggs, milk, oats, wheat, cod, salmon, and shrimp). A dry heat sterilization method similar to the dry heat sterilization method of interest to the present disclosure is described in US2014 / 0023757, which is incorporated herein by reference.
[0095] The bulk mixed allergenic material blended as described in Example 2 or 3 may be placed in a heat resistant packaging bag. The bagged bulk mixed allergenic material may then be placed in an insulated processing chamber, wherein heat is provided to the processing chamber by a plurality of natural gas burners. A plurality of intake and exhaust pipes may be used to circulate heat through the insulated processing chamber to promote uniform heat absorption by the bagged bulk mixed allergenic material.
[0096] For example, 6 bags of loose mixed allergenic raw materials (each weighing approximately 25 lbs / 12 kg) may be placed as a single layer on a pallet, and 14 pallets may be loaded into a heating chamber having dimensions of 40 feet long, 10 feet high, and 9 feet wide.
[0097] The heating chamber can then be sealed and the chamber can be heated to reach a target temperature of 74° C. The warm-up time for the chamber to reach the target temperature may take about 24 hours.
[0098] The temperature of the heating chamber can be monitored using six probes in the heating chamber, for example, two probes can be placed at the rear of the heating chamber, two probes can be placed in the middle of the heating chamber, and two probes can be placed at the front of the heating chamber.
[0099] Once the target temperature is reached, the heated chamber may be maintained for a 24 hour period.
[0100] The temperature of the insulated processing chamber, multiple natural gas fired ovens, and bagged loose mixed allergenic raw materials may be monitored to ensure that the loose mixed allergenic raw materials are dry heat sterilized using a temperature of about 65°C to about 175°C for a period of 24 hours.
[0101] After dry heat treatment, the sterilized mixed allergen product can be unloaded from the heating chamber. The water activity, humidity level, and total plate count of the sterilized mixed allergen product sample can be measured and compared to a sample of the bulk mixed allergen raw material prior to dry heat sterilization.
[0102] For example, the sample can be diluted and plated on a Petri dish with normal recovery medium to measure colony forming units (CFU / g) per gram of product or material for total aerobic microorganisms and enterobacteriaceae counts. The sample can be diluted and plated on a 3M Petrifilm® plate according to the manufacturer's instructions (3M, St. Paul, Minnesota). TM E. coli / Coliforms and 3M Petrifilm TM Escherichia coli / coliforms and Staphylococcus aureus were determined on Staph Express counting plates.
[0103] According to the manufacturer's instructions, use Samples were additionally tested for the presence of Listeria and Salmonella using the PCR detection system (Hygiena, Camarillo, California).
[0104] Alternatively, the sample can be diluted and spread onto 3M Petrifilm according to the manufacturer's instructions. TM Total mold and yeast counts were determined on mold and yeast count plates.
[0105] Example 6
[0106] This example describes the validation of a dry heat process for the sterilization of loose mixed allergenic raw materials.
[0107] In this dry heat method, Enterococcus faecium 8459 strain 1830 was used as a surrogate microorganism to evaluate the lethality of dry heat sterilization against Salmonella and Cronobacter pathogens. 1830 has a thermotolerance similar to or greater than that of Salmonella and Cronobacter. At least a 5-log reduction in the number of 1830 organisms was achieved. Two validation experiments were performed to assess variability.
[0108] Before dry heat sterilization, use about 1.4 x 10 6 1830 organisms were inoculated into 70 heat-resistant bags, each containing 25 grams of loose mixed allergenic material blended as described in Example 2 or 3. Each inoculated heat-resistant bag was placed into a box.
[0109] The six inoculated loose mixed allergen material bags were not introduced into the dry heat sterilization process and served as untreated control samples.
[0110] For verification tests 1 and 2, 14 pallets were loaded into the Figure 2A and 2B In the heating chamber shown in FIG. 1 , each tray contains four boxes of inoculated heat-resistant bags of loose mixed allergen material. On trays #1, #6, #9, and #14, a second inoculated heat-resistant bag of loose mixed allergen material is placed in box #3 and / or #4.
[0111] The temperature of the heating chamber is monitored throughout the validation run using heating chamber probes: two located at the front of the heating chamber, two located in the middle of the heating chamber, and two located at the back of the heating chamber. In addition, a MadgeTech probe is included to monitor the temperature of the heating chamber during dry heat sterilization. The MadgeTech probe is placed inside the heat-resistant bag where the inoculated loose mixed allergenic material has been selected, or outside the box.
[0112] As in verification tests 1 and 2, respectively Figure 3A and 3B As shown in , the temperatures recorded by the MadgeTech probes are relatively uniform at different locations within the chamber. The temperatures recorded by the heated chamber probes vary depending on the location within the chamber (i.e., rear, middle, or front), but are relatively similar between two probes at the same location during dry heat sterilization processing.
[0113] For verification test 1( Figure 3A ), the dry heat treatment was initially set at 175°F / 80°C. It took 18 hours for all probes to reach the target temperature. Once the target temperature was reached, the temperature was reduced to 165°F / 74°C and maintained at this temperature for another 24 hours.
[0114] For verification test 2 ( Figure 3B ), the dry heat treatment was set at 165°F / 74°C. It took 17 hours for all probes to reach the target temperature. Once the target temperature was reached, the dry heat sterilization temperature was maintained at 165°F / 74°C for an additional 24 hours.
[0115] As shown in Table 2, the water activity and moisture content of the sterilized mixed allergen product after dry heat sterilization in Validation Test 1 were lower than those of the loose mixed allergen raw material before dry heat treatment. The total plate counts on the selective medium were similar for the loose mixed allergen raw material before dry heat sterilization and the mixed allergen product after dry heat sterilization.
[0116] Table 2
[0117]
[0118] As shown in Table 3, the loose mixed allergenic raw material samples that were not sterilized by dry heat had an average of 8.1±0.1 log cfu / g. 1830 and counting.
[0119] Table 3
[0120]
[0121] As shown in Table 4, in Validation Test 1, dry heat sterilization achieved a significant improvement in all samples compared to the inoculated loose mixed allergenic raw material samples that were not dry heat treated. Greater than 5 log reduction of 1830 CFU / g.
[0122] Table 4
[0123]
[0124]
[0125]
[0126] As shown in Table 5, the water activity of the sterilized mixed allergen product after dry heat sterilization in Validation Test 2 was similar to the water activity of the loose mixed allergen raw material before dry heat treatment. Compared with the loose mixed allergen raw material without dry heat sterilization, the moisture content and total plate count after dry heat sterilization in Validation Test 2 were lower.
[0127] Table 5
[0128]
[0129] As shown in Table 6, the loose mixed allergenic raw material samples that were not dry heat sterilized had an average of 8.1±0.1 log cfu / g. 1830 and counting.
[0130] Table 6
[0131]
[0132] As shown in Table 7, similar to dry heat sterilization in Validation Study 1, dry heat sterilization in Validation Study 2 resulted in a decrease in all samples compared to the inoculated loose mixed allergenic raw material samples that were not dry heat treated. Greater than 5 log reduction of 1830 CFU / g.
[0133] Table 7
[0134]
[0135]
[0136]
[0137] Example 7
[0138] The particle size distribution of mixed allergen product samples treated with dry heat sterilization can be measured and compared to the particles of the corresponding loose mixed allergen material that has not been subjected to the dry heat sterilization application. The sample was filtered for 3 minutes through a vibrating screen and a series of mesh sizes consisting of: #10, #12, #14, #16, #18, #20, #25, #30, #35, #40 and #50 screens. The filtered particles and the particles retained by each screen were removed individually, weighed, and the distribution was plotted as a graph of % weight versus particle size in microns.
[0139] Example 8
[0140] The protein integrity of mixed allergen product samples treated with dry heat sterilization can be compared to bulk mixed allergen material that has not been subjected to dry heat sterilization application. Protein integrity can be assessed by resolving all proteins present in the non-sterilized and dry heat sterilized samples by SDS-PAGE.
[0141] 1 mg of loose mixed allergen material or dry heat sterilized mixed allergen product can be weighed into a 2 ml microtube. Based on their estimated protein concentration, samples can be diluted to a protein concentration of 1 mg / ml with Laemmli buffer containing 5% 2-mercaptoethanol (BioRad, Hercules, CA). The protein suspension can be mixed by gentle inversion or intermittent vortexing for 5 minutes and then heated to 95°C to 100°C for 5 minutes. Samples can be centrifuged at 1,000 RPM for 1 minute and then 10 microliters of each sample per well can be loaded in triplicate on a 4-20% polyacrylamide gradient gel (BioRad, Hercules, CA) immersed in 1X SDS-PAGE running buffer (BioRad, Hercules, CA). The gel can be run at 100 V for 80-90 minutes (or 200 V for 30-40 minutes). The gel can then be washed 3 times with distilled water at room temperature on an orbital shaker for 5 minutes each wash. Gels can be fixed in fixative (Sigma-Aldrich, St.Louis, Missouri) or 50% methanol, 10% acetic acid for 15 minutes. Gels can be stained with EXBlue gel staining reagent (Sigma-Aldrich, St.Louis, Missouri) for 2 hours or overnight, and then removed by washing in distilled water for 1-2 hours or overnight. When washing is complete, the gel can be covered with transparent plastic and scanned using a gel reader. Protein band density determination can be analyzed using ImageJ public domain software (NIH, Bethesda, Maryland).
[0142] Example 9
[0143] The visual and sensory characteristics of samples of mixed allergen products treated with dry heat sterilization can be compared to bulk mixed allergen materials that have not been subjected to dry heat sterilization. A comparison of the taste characteristics of mixed allergen products sterilized with dry heat and unsterilized bulk mixed allergens can also be made.
[0144] Incorporation of References
[0145] All publications and patents mentioned in this specification are incorporated by reference in their entirety for all purposes. In the event of a conflict, the present application, including any definitions in this application, will control.
[0146] Equivalent solutions
[0147] Although specific embodiments of the present invention have been discussed, the above description is exemplary and non-restrictive. After reading this specification, many variations of the present invention will become apparent to those skilled in the art. The full scope of the present invention should be determined by reference to the full scope of the claims and their equivalents and this specification and these variations.
[0148] Unless otherwise indicated, all numerical values expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by the present invention.
Claims
1. A method for preparing a mixed allergen product substantially free of viable and replicating organisms, comprising: Providing loose mixed allergen materials containing 2 to 20 individual whole food allergens; as well as The loose mixed allergen raw material is sterilized by dry heat sterilization, thereby obtaining the mixed allergen product.
2. The method of claim 1, further comprising providing 2 to 20 individual whole food allergens and blending the 2 to 20 individual whole food allergens together to obtain the bulk mixed allergen material.
3. The method of claim 2, wherein the individual whole food allergens are selected from the group consisting of almonds, cashews, cod, eggs, hazelnuts, milk, oats, peanuts, pecans, pistachios, salmon, sesame, shrimp, soy, walnuts, and wheat.
4. The method of claim 2 or 3, wherein said blending further comprises blending said 2 to 20 individual whole food allergens with one or more than one filler.
5. The method of any one of claims 2 to 4, wherein the blending comprises feeding the 2 to 20 individual whole food allergens into a ribbon blender set at about 10 Hz to about 50 Hz for about 10 minutes to about 50 minutes.
6. A method according to any one of claims 2 to 5, wherein after blending, the bulk mixed allergenic raw material is discharged into a lined vat.
7. The method of any one of claims 1-6, wherein the dry heat sterilization is performed at a temperature of about 65°C to about 175°C for about 18 hours to about 72 hours.
8. The method of claim 7, wherein the dry heat sterilization comprises using a sterilization system having an oven and a heating chamber, wherein the oven provides about 250,000 BTU to about 750,000 BTU of heat to the heating chamber.
9. The method of claim 7 or 8, wherein the loose mixed allergenic raw material is first packaged into a heat-resistant package before sterilization.
10. A method according to any one of claims 7 to 9, wherein a temperature probe is placed with the loose mixed allergenic raw material during the sterilisation process to monitor the temperature of dry heat sterilisation.
11. The method of any one of claims 1 to 10, wherein the mixed allergen product has at least about a 1 log reduction to at least about a 4 log reduction in aerobic biological plate counts compared to a corresponding bulk mixed allergen material that has not been sterilized.
12. The method of any one of claims 1 to 11, wherein the mixed allergen product has less than about 100,000 CFU / g of aerobic organisms.
13. The method of any one of claims 1 to 12, wherein the mixed allergen product has less than about 10 CFU / g of coliform bacteria.
14. The method of any one of claims 1 to 13, wherein the mixed allergen product has less than about 10 CFU / g of E. coli.
15. The method of any one of claims 1 to 14, wherein the mixed allergen product has less than about 10 CFU / g of Enterobacteriaceae.
16. The method of any one of claims 1 to 15, wherein the mixed allergen product has less than about 10 CFU / g of Salmonella.
17. The method of any one of claims 1 to 16, wherein the mixed allergen product has less than about 10 CFU / g of Cronobacter.
18. The method of any one of claims 1 to 17, wherein said mixed allergen product is negative for Listeria species or Cronobacter species in a PCR-based assay per 25 grams of said mixed allergen product.
19. The method of any one of claims 1 to 18, wherein the mixed allergen product has less than about 10 CFU / g of mold.
20. The method of any one of claims 1 to 19, wherein said mixed allergen product is negative for Salmonella species in a PCR-based assay per 375 grams of said mixed allergen product.
21. The method of any one of claims 1 to 20, wherein the mixed allergen product has less than about 10 CFU / g of Staphylococcus aureus.
22. The method of any one of claims 1 to 21, wherein the mixed allergen product has less than about 10 CFU / g of yeast.
23. A method according to any one of claims 1 to 22, wherein the mixed allergen product has a fat content of about 10% to about 20% by weight.
24. A method according to any one of claims 1 to 23, wherein the protein integrity of the mixed allergen product is substantially similar to the protein integrity of the corresponding bulk mixed allergen raw material which has not been sterilised.
25. The method of claim 24, wherein the protein integrity of the mixed allergen product is determined by SDS-PAGE.
26. A method according to any one of claims 1 to 25, wherein the mixed allergen product has a protein content of about 40% to about 50% by weight.
27. The method of any one of claims 1 to 26, wherein the mixed allergen product has from about 1% to about 10% moisture by weight.
28. The method of any one of claims 1 to 27, wherein the mixed allergen product has a water activity of about 0.1 to about 0.
6.
29. The method of any one of claims 1 to 28, wherein less than about 10% by weight of the mixed allergen product is particles having a diameter greater than 500 microns.
30. A method according to any one of claims 1 to 29, wherein the mixed allergen product is darker in colour than the corresponding loose mixed allergen material which has not been sterilised.
31. The method of any one of claims 1 to 30, wherein the mixed allergen product has a substantially similar taste profile compared to a corresponding bulk mixed allergen material that has not been sterilised.
32. The method of any one of claims 1 to 31, wherein sterilizing further comprises one or more additional applications of dry heat sterilization.
33. A method of preparing a mixed allergen product substantially free of viable, replicating organisms, comprising: Provides 2 to 20 separate complete food allergens; sterilizing each of the 2 to 20 individual whole food allergens by dry heat sterilization, thereby obtaining 2 to 20 sterilized individual whole food allergens; as well as The 2 to 20 sterilized individual whole food allergens are blended together to obtain the mixed allergen product.
34. The method of any one of claims 1 to 33, further comprising admixing the mixed allergen product with one or more than one probiotic bacteria.
35. The method of claim 34, wherein the one or more than one probiotic is selected from the group consisting of Lactobacillus rhamnosus, Corynebacterium faecalis, and Bifidobacterium longum.
36. The method of any one of claims 1 to 35, further comprising admixing the mixed allergen product with one or more than one prebiotic.
37. The method of claim 36, wherein the prebiotic is fructooligosaccharide.
38. The method of any one of claims 1 to 37, further comprising filtering the mixed allergen product.
39. The method of claim 38, wherein the mixed allergen product is filtered through a screen ranging from a #5 mesh (US) screen to a #10 mesh (US) screen on an oscillator for about 1 minute to about 10 minutes.
40. The method of any one of claims 1 to 39 further comprising passing the mixed allergen product through a rare earth magnet, a metal detector and a metal separator.
41. A mixed allergen product substantially free of viable replicating organisms prepared by the process of any one of claims 1 to 40.
